STAT+: Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s
Flagship Pioneering is gearing up to launch a new company that seems to be developing…
Author: STAT
STAT+: Targeting prices for accelerated approval drugs may have limited impact on overall drug spending
As U.S. regulators approve more medicines under the accelerated approval pathway, Medicare and Medicaid continue…
.jpg)
STAT+: Acadia drug meets endpoints for treating Rett syndrome, a rare neurological disease
An experimental drug being developed by Acadia Pharmaceuticals improved the symptoms of women and girls…
.jpg)
STAT+: As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform
WASHINGTON — President Biden promised Monday that Democrats’ signature drug pricing plan will mean no…
Salary gap between male and female physicians adds up to $2 million in lifetime earnings
Women may now equal or outnumber men in medical school classes, but their lifetime earnings…
STAT+: An advocacy group seeks to broaden access to a Pfizer Covid-19 pill
In a bid to expand access to the Pfizer (PFE) Covid-19 pill, an advocacy group…
Opinion: Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing
The Senate began its confirmation hearing last week for President Biden’s nominee to head the…
STAT+: Pharmalittle: Covid-19 pills may take longer to reach poor countries; J&J Covid booster may be as beneficial as a third Pfizer shot
Hello, everyone, and welcome to another working week. We hope the weekend respite was relaxing…
Opinion: It’s time to open up health care’s secret analytics
Each year as older adults begin choosing between traditional fee-for-service Medicare and Medicare Advantage, they…
Opinion: Covid-19 is fueling a pandemic of violence against women and girls
The emergence of the Omicron variant of SARS-CoV-2 with its many mutations has rightly sparked…
Patients and doctors are clashing about side effects of hormonal birth control
When a pediatrician put Maya Prokupets on the birth control pill at age 15 to…
STAT+: The pandemic forced an experiment in delivering intensive mental health care from home. Will the approach stick?
When the pandemic lockdowns slammed society’s doors closed in March 2020, the leaders at McLean…
Early data from South Africa hints Omicron variant may cause less severe Covid, but more research is needed
As the world waits for studies that give a clear picture of the Omicron variant,…
STAT+: Stoke Therapeutics drug, targeting genetic cause of childhood epilepsy, reduces seizure activity
An experimental drug from Stoke Therapeutics reduced the frequency of convulsive seizures in children with…
STAT+: Pharmalittle: FDA plans rapid review of Omicron vaccines and drugs; Califf would keep Woodcock at FDA
And so, another working week will soon draw to a close. Not a moment too…
Opinion: In defense of not treating everyone the same
As a third-generation Black physician who has experienced firsthand discrimination from health care providers, I…
Opinion: Reforms needed for FDA’s regulation of medical devices
Medical devices are mainstays of modern medicine, from basic products like gloves and bandages to…
We’ll know more soon about Omicron. Here’s how to interpret the coming flood of data
At some point in the next few weeks, scientists will start releasing data from lab…
‘Just stupid stuff’: Logistics and lack of testing stymied finding the Omicron variant in the U.S.
After South African scientists alerted the world last week to the new, concerning Omicron variant…
STAT+: Former Immunomedics executives are charged with insider trading
Two former executives at Immuomedics were charged with insider trading by U.S. authorities in connection…
Califf, nominee to lead FDA, asks Woodcock to stay in leadership role if he’s confirmed
WASHINGTON — Robert Califf, President Biden’s pick to lead the Food and Drug Administration, has…
Virtual care companies rush to ease access to Covid-19 antivirals
As two new antiviral pills for Covid-19 approach emergency authorization, experts are concerned that a…
Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron
Will the first Covid-19 pill be all that useful? How worrisome is Omicron? And when…
STAT+: Hospitals and doctors fail to stop end-of-year Medicare cuts, for now
WASHINGTON — Hospitals and physicians lost a lobbying battle to stave off Medicare cuts of…
Second U.S. case of Omicron variant indicates domestic transmission
Health officials on Thursday reported the country’s second Covid-19 infection from the Omicron variant in…
Most advanced lab-grown human embryos prompt a pressing question: Are they getting too real?
The stem cells were no more than a week old when scientists moved them from…
Docs pitch the C-suite on tech & why telehealth pricing matters
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Glaxo and Vir drug appears to work against Omicron; employees sue Bristol Myers over vaccine mandate
Rise and shine, another busy day is on the way. However, this is also shaping…
Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’
WASHINGTON — President Joe Biden will announce a new plan this afternoon for combating the…
Opinion: The Fifth Circuit Court got the science wrong on OSHA’s vaccination mandate
In mid-November, a federal judicial panel assigned the Cincinnati-based United States Court of Appeals for…
Opinion: Another fight for Covid long-haulers: having their pain acknowledged
After his second hospitalization for acute Covid-19, Tony Marks expected to get better. Then pain…
STAT+: Artificial intelligence is making a pitch to transform radiology. Will it pay off for hospitals?
For radiologists working today, the specter of artificial intelligence is inescapable. In the past year,…
Some experts suggest Omicron variant may have evolved in an animal host
When Covid-19 variants arise, the accepted wisdom is that the constellation of mutations they contain…
STAT+: Liquid biopsies could help screen for countless cancers. But who should get them?
By the time cancer is discovered, it’s often too late to change its course. Close…
STAT+: Amgen joins a growing list of drug makers cutting discounts to safety-net hospitals
Amid a closely watched legal battle, Amgen (AMGN) has joined the growing ranks of major…
First case of Omicron coronavirus variant identified in the U.S.
U.S. health officials on Wednesday reported the country’s first case of the Omicron variant of…
STAT+: Pharmalittle: Merck Covid pill squeaks past FDA panel; analysis explores whether insurers give ‘fair access’ to drugs
Top of the morning to you, and a fine one it is. A shiny sun…
STAT+: Just how many barriers do health insurers create to fair access to medicines?
Do large health insurers in the U.S. provide “fair access” to prescription medicines? The answer…
STAT+: In a medical first, Vertex drug successfully targets the underlying cause of a genetic kidney disease
An experimental pill from Vertex Pharmaceuticals reduced levels of a damaging urine protein by nearly…
STAT+: Socially responsible investor coalitions push greater access to medicines in shareholder proposals
Amid controversy over equitable distribution of Covid-19 vaccines, a large coalition of socially minded investor…
Opinion: Listen: Who owns your health data — and why you should care
It can be hard to fathom that anyone other than you might own your information….
Opinion: Losing Faith: Reflecting on 40 years of the HIV pandemic
Faith was the first child I lost to HIV. I can still see her, sitting…
Opinion: Stigma, not science, is the biggest barrier to ending the HIV epidemic
“I am really sorry to reach out like this, David, but I’m worried about my…
7 policies in Biden’s spending plan aimed at health equity
WASHINGTON — Democrats have made big promises to tackle racial inequities across society, including in…
A reason for optimism on Omicron: Our immune systems are not blank slates
The emergence of a new Covid-19 variant with a startlingly large constellation of mutations has…
FDA panel narrowly recommends authorization of Merck Covid pill after day of tense discussion
A panel of experts convened by the Food and Drug Administration voted by a slim…
Holmes admits to misstep & Amazon scores a big health cloud client
Holmes admits to one key misstep in Theranos debacle Since Elizabeth Holmes first took the…
Despite interventions, Black and Hispanic men are contracting HIV at the same rates as 10 years ago
Despite numerous advances in the prevention of HIV, new data show that the rate of…
States: Sackler family members abusing bankruptcy process
NEW YORK — A federal judge should reject a sweeping settlement to thousands of lawsuits…
STAT+: Pharmalittle: Moderna CEO cautions Covid shots will be less effective against Omicron; Pfizer predicts new vaccine for the variant in 100 days
Rise and shine, everyone, another busy day is on the way. We can tell because…